The impact of carvedilol on the defibrillation threshold

Heart and Lung: Journal of Acute and Critical Care

Volumn 37, Issue 1, 2008, Pages 67-71

  McBride, Brian F ^a   White, C Michael ^b,c   Kalus, James S ^b,c   Guertin, Danette C ^c   Clyne, Christopher A ^c   Baker, William L ^c   Kluger, Jeffery ^c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c HARTFORD HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NORADRENALIN; PLACEBO; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 38149036545     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2007.04.005     Document Type: Article

References (11)

1. Greenberg H., Case R.B., Moss A.J., Brown M.W., Carroll E.R., Andrews M.L., et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT II). J Am Coll Cardiol 43 (2004) 1459-1465
2. Ideker R.E., Wolf P.D., and Tang A.S. Mechanisms of defibrillation. In: Tacker W.A. (Ed). Defibrillation of the Heart (1994), Mosby-Year Book, Inc, St. Louis, MO 15-45
3. Guarnieri T., Levine J.H., Veltri E.P., Griffith L.S., Watkins L.J.R., Juanteguy J., et al. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 60 (1987) 1061-1064
4. Babbs C.F. Effects of drugs on defibrillation threshold. In: Tacker W.A. (Ed). Defibrillation of the Heart (1994), Mosby-Year Book, Inc, St. Louis, MO 223-258
5. Morady F., Nelson S.D., Kou W.H., Pratley R., Schmaltz S., De Buitleir M., et al. Electrophysioligc effects of epinephrine in humans. J Am Coll Cardiol 11 (1988) 1235-1244
6. Sousa J., Kou W., Calkins H., Rosenheck S., Kadish A., and Morady F. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 69 (1992) 509-512
7. Kalus J.S., White C.M., Caron M.F., Guertin D.C., McBride B.F., and Kluger J. The impact of elevations in catecholamine concentrations on defibrillation threshold in patients with implanted cardioverter-defibrillators. PACE 28 (2005) 1147-1156
8. Albert C., Mittleman M.A., Chae C.U., Lee I.M., Hennekens C.H., and Manson J.E. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343 (2000) 1355-1361
9. Frishman W.H. Alpha- and beta-blocking drugs. In: Frishman W.H., Sonneblick E.H., and Sica D.A. (Eds). Cardiovascular Pharmacotherapeutics Manual. Second Edition (2004), McGraw-Hill, New York, NY 19-57
10. Pharand C., Goldman R., Fan C., Chow M., and Kluger J. Effect of chronic oral moricizine and intravenous epinephrine on ventricular fibrillation and defibrillation thresholds. PACE 19 (1996) 82-89
11. Morillo C.A., Jones D.L., and Klein G.J. Effects of autonomic manipulation on ventricular fibrillation and internal cardiac defibrillation threshold in pigs. PACE 19 (1996) 1355-1362